ACCURUN 342 CT/NG Nucleic Acid Positive Control Series 100 - EUDAMED Registration 00816784020680

Access comprehensive regulatory information for ACCURUN 342 CT/NG Nucleic Acid Positive Control Series 100 in the European Union medical device market through Pure Global AI's free database. This IVD Annex II List B device is registered with EU EUDAMED under Primary DI 00816784020680 and manufactured by LGC Clinical Diagnostics, Inc. in United States.

This page provides complete registration details including trade name (ACCURUN 342 CT/NG Nucleic Acid Positive Control Series 100), manufacturer information, authorized representative details, competent authority (Agence Nationale de Sécurité du Médicament et des Produits de Santé), and regulatory compliance data from the official EU EUDAMED medical device database. Pure Global AI offers free access to the European Union's complete medical device registry, helping global MedTech companies navigate EU MDR regulations efficiently.